A growth-hormone-releasing analogue, researched for natural secretion patterns.
Sermorelin is a synthetic analog of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). Research suggests it engages GHRH receptors on anterior pituitary somatotrophs to support pulsatile GH secretion, more closely mirroring physiological release patterns compared to exogenous GH administration. Preclinical data indicates downstream engagement of IGF-1 signaling pathways associated with protein synthesis, cellular repair, and metabolic regulation. Intended for research purposes.


Sermorelin is a synthetic analog of the first 29 amino acids of endogenous GHRH. Research suggests it engages GHRH receptors on pituitary somatotrophs to support pulsatile GH secretion, more closely mirroring natural release patterns than exogenous GH, with downstream engagement of IGF-1 pathways tied to protein synthesis and cellular repair.
Research Use Only. These products have not been evaluated or approved by the FDA for use as drugs, therapeutics, diagnostics, or dietary supplements, and are not intended for administration to humans or animals. No product description or mechanism-of-action information constitutes a health claim or therapeutic endorsement. Any clinical use is at the sole discretion of a licensed healthcare provider in compliance with applicable laws. Individual results may vary.